Search research articles
Contact Us
Filters
Showing results (1-10 of 4) with videos related to
Page
of 1
Sort By:
Archives of Cardiovascular Diseases
|
February 7, 2024
Bradycardia risk stratification with implantable loop recorder after unexplained syncope
Guillaume De Ciancio, Nicolas Sadoul, Nefissa Hammache, et al.
Archives of Cardiovascular Diseases
|
November 7, 2021
Adherence to diagnostic and therapeutic practice guidelines for suspected cardiac implantable electronic device infections
Guillaume De Ciancio, Marie-Line Erpelding, Laura Filippetti, et al.
Intensive Care Medicine Experimental
|
August 13, 2023
Soluble TREM-1 plasma concentration predicts poor outcome in COVID-19 patients
Sébastien Gibot, Thomas Lafon, Laurent Jacquin, et al.
Eclinicalmedicine
|
June 23, 2023
Effect of weight-adjusted intermediate-dose versus fixed-dose prophylactic anticoagulation with low-molecular-weight heparin on venous thromboembolism among noncritically and critically ill patients with COVID-19: the COVI-DOSE trial, a multicenter, randomised, open-label, phase 4 trial
Stéphane Zuily, Benjamin Lefèvre, Olivier Sanchez, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 4) with videos related to
Sort By:
Page
of 1
Archives of Cardiovascular Diseases
|
February 7, 2024
Bradycardia risk stratification with implantable loop recorder after unexplained syncope
Guillaume De Ciancio, Nicolas Sadoul, Nefissa Hammache, et al.
Archives of Cardiovascular Diseases
|
November 7, 2021
Adherence to diagnostic and therapeutic practice guidelines for suspected cardiac implantable electronic device infections
Guillaume De Ciancio, Marie-Line Erpelding, Laura Filippetti, et al.
Intensive Care Medicine Experimental
|
August 13, 2023
Soluble TREM-1 plasma concentration predicts poor outcome in COVID-19 patients
Sébastien Gibot, Thomas Lafon, Laurent Jacquin, et al.
Eclinicalmedicine
|
June 23, 2023
Effect of weight-adjusted intermediate-dose versus fixed-dose prophylactic anticoagulation with low-molecular-weight heparin on venous thromboembolism among noncritically and critically ill patients with COVID-19: the COVI-DOSE trial, a multicenter, randomised, open-label, phase 4 trial
Stéphane Zuily, Benjamin Lefèvre, Olivier Sanchez, et al.
Page
of 1